What Researchers Did
The researchers treated 33 cases of bone damage caused by radiation in the head and neck using a step-by-step approach that combined surgery to remove dead bone with hyperbaric oxygen therapy.
What They Found
In a prospective study of 33 head and neck osteoradionecrosis cases treated with sequestrectomy plus hyperbaric oxygen therapy, the control rate was 77% (20 of 26) among the cases that did not involve recurrent cancer. Treatment took place from July 1993 to June 1998. Seven of the 33 cases (21%) turned out to have recurrent cancer. The authors noted that bone damage that persists despite thorough treatment raises suspicion of recurrent cancer.
What This Means for Canadian Patients
For people with osteoradionecrosis in the head and neck, this study describes a combined approach of surgery and hyperbaric oxygen therapy. The authors state that surgery still plays a major role in controlling the condition and that hyperbaric oxygen therapy is an adjuvant, meaning an add-on. They advise that extensive disease, such as multiple discharging fistulas, a large area of exposed dead bone, or a fracture, should be treated mainly with radical sequestrectomy and microvascular free flap reconstruction.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a single group of 33 cases with no comparison group, so it cannot show how much of the 77% control rate came from hyperbaric oxygen therapy rather than surgery.